IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Long-Term Debt Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Long-Term Debt
kr24.6m
CAGR 3-Years
169%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Long-Term Debt
kr1B
CAGR 3-Years
562%
CAGR 5-Years
191%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Long-Term Debt
kr10.6m
CAGR 3-Years
-16%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Long-Term Debt
kr1.6B
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Long-Term Debt
kr3.5m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Long-Term Debt
kr700k
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Long-Term Debt?
Long-Term Debt
24.6m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Long-Term Debt amounts to 24.6m SEK.

What is IRLAB Therapeutics AB's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
169%

Over the last year, the Long-Term Debt growth was 6 364%. The average annual Long-Term Debt growth rates for IRLAB Therapeutics AB have been 169% over the past three years .

Back to Top